Sponsor:
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Code:
NCT06335407
Conditions
Alcohol Use Disorder (AUD)
Post Traumatic Stress Disorder (PTSD)
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Not accepted
Interventions
Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg
Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-05. This information was provided to ClinicalTrials.gov by Pharmacotherapies for Alcohol and Substance Use Disorders Alliance on 2025-10-27.